170 related articles for article (PubMed ID: 361576)
1. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.
Milligan TW; Baker CJ; Straus DC; Mattingly SJ
Infect Immun; 1978 Sep; 21(3):738-46. PubMed ID: 361576
[TBL] [Abstract][Full Text] [Related]
2. Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates.
Mattingly SJ; Milligan TW; Pierpont AA; Straus DC
J Clin Microbiol; 1980 Oct; 12(4):633-5. PubMed ID: 6999031
[TBL] [Abstract][Full Text] [Related]
3. Protease production by clinical isolates of type III group B streptococci.
Straus DC; Mattingly SJ; Milligan TW; Doran TI; Nealon TJ
J Clin Microbiol; 1980 Sep; 12(3):421-3. PubMed ID: 7012176
[TBL] [Abstract][Full Text] [Related]
4. Extracellular neuraminidase production by group B streptococci.
Milligan TW; Straus DC; Mattingly SJ
Infect Immun; 1977 Oct; 18(1):189-95. PubMed ID: 332641
[TBL] [Abstract][Full Text] [Related]
5. In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.
Maurer JJ; Mattingly SJ
J Clin Microbiol; 1988 Apr; 26(4):686-91. PubMed ID: 3284898
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neuraminidases produced by various serotypes of group B streptococci.
Brown JG; Straus DC
Infect Immun; 1987 Jan; 55(1):1-6. PubMed ID: 3539798
[TBL] [Abstract][Full Text] [Related]
7. Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40 degrees C.
Mattingly SJ; Maurer JJ; Eskew EK; Cox F
J Clin Microbiol; 1990 Jul; 28(7):1676-7. PubMed ID: 2199528
[TBL] [Abstract][Full Text] [Related]
8. Group B streptococci: extracellular neuraminidase production and virulence in mouse.
Orefici G; De Stasio A; Guarino M; Martini A; Orsi N
Microbiologica; 1984 Jan; 7(1):75-8. PubMed ID: 6374384
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease.
Nealon TJ; Mattingly SJ
Infect Immun; 1983 Mar; 39(3):1243-51. PubMed ID: 6341233
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.
Nagano Y; Nagano N; Takahashi S; Suzuki A; Okuwaki Y
J Clin Microbiol; 1989 Oct; 27(10):2148-51. PubMed ID: 2685015
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
Durham DL; Mattingly SJ; Doran TI; Milligan TW; Straus DC
Infect Immun; 1981 Nov; 34(2):448-54. PubMed ID: 7030959
[TBL] [Abstract][Full Text] [Related]
12. Purification and partial characterization of neuraminidase from type III group B streptococci.
Milligan TW; Mattingly SJ; Straus DC
J Bacteriol; 1980 Oct; 144(1):164-71. PubMed ID: 6998945
[TBL] [Abstract][Full Text] [Related]
13. Group B streptococcal neuraminidase is actually a hyaluronidase.
Pritchard DG; Lin B
Infect Immun; 1993 Aug; 61(8):3234-9. PubMed ID: 8335355
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing release of type III antigens by group B streptococci.
Doran TI; Straus DC; Mattingly SJ
Infect Immun; 1981 Feb; 31(2):615-23. PubMed ID: 7012015
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.
Musser JM; Mattingly SJ; Quentin R; Goudeau A; Selander RK
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4731-5. PubMed ID: 2660146
[TBL] [Abstract][Full Text] [Related]
16. High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.
Palacios GC; Gonzalez MN; Beltran M; Arredondo JL; Torres J; Solorzano F
Curr Microbiol; 2007 Jan; 54(1):42-7. PubMed ID: 17171465
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and immunological characterization of the extracellular nucleases of group B streptococci.
Ferrieri P; Gray ED; Wannamaker LW
J Exp Med; 1980 Jan; 151(1):56-68. PubMed ID: 6985648
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.
Shigeoka AO; Rote NS; Santos JI; Hill HR
J Infect Dis; 1983 May; 147(5):857-63. PubMed ID: 6341485
[TBL] [Abstract][Full Text] [Related]
19. Detection and comparison of neuraminidase activities in human and bovine group B streptococci.
Ekin IH; Gurturk K; Ilhan Z; Ekin S; Borum AE; Arabaci C; Yesilova A
APMIS; 2016 Dec; 124(12):1093-1098. PubMed ID: 27714850
[TBL] [Abstract][Full Text] [Related]
20. Role of adherence in the pathogenesis of neonatal group B streptococcal infection.
Broughton RA; Baker CJ
Infect Immun; 1983 Feb; 39(2):837-43. PubMed ID: 6339391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
